课题基金 / 基金详情

Increased urinary excretion of bilirubin oxidative metabolites in septic patients: a new marker for ocidative stress in vivo

Increased urinary excretion of bilirubin oxidative metabolites in septic patients: a new marker for ocidative stress in vivo
脓毒症患者尿中胆红素氧化代谢物排泄增加:体内氧化应激的新标志物
批准号:
12671234
负责人:
SHIMIZU Shuji
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

SHIMIZU Shuji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background. Bilirubin oxidative metabolites (BOMs) are generated from bilirubin as a result of its scavenging action against free radicals. During sepsis, excess amounts of free radicals are produced, and they play an important role in the pathophysiological process. We studied whether urinary excretion of BOMs would increase under septic conditions in humans and compared BOM levels with other well-established clinical parameters of inflammation.Methods. In 19 septic patients and 28 nonseptic control patients, the BOM concentrations in urine were measured by enzyme-linked immunosorbent assay with an anti-bilirubin antibody.Results. Urinary BOM levels in septic patients were much higher than those in control patients (21.6±2.5 v.s. 1.4±0.4 mol/g creatinine, P < 0.001). Although there was a linear correlation between urinary BOM and serum total bilirubin levels (r = 0.392, P = 0.008), serum bilirubin levels were not significantly higher in the septic group than in the control group (P = 0.072). BOM levels correlated with body temperature (r = 0.801, P < 0.001), white blood cell counts in the peripheral blood (r = 0.590, P < 0.001), serum C-reactive protein (r = 0.653, P < 0.001), and the acute physiological and chronic health evaluation (APACHE II) score (r = 0.467, P = 0.003).Conclusions. These results demonstrated a urinary increase in BOMs in septic patients. This increase indicates that urinary BOM level is a possible marker for continuous monitoring of sepsis severity in clinical practice.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Kazahiro Otani, Shuji Shimizu, Kazuo Chijiiwa, et al.: "Increased urinary excretion of bilirubin oxidative metabolites in septic patients : a new marker for oxidative stress"Journal of Surgical Research. 96. 44-49 (2001)
Kazahiro Otani、Shuji Shimizu、Kazuo Chijiiwa 等人:“脓毒症患者胆红素氧化代谢物尿排泄增加:氧化应激的新标志物”《外科研究杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuhiro Otani, Shuji Shimizu, Kazuo Chijiiwa, et al.: "Increased urinary excretion of bilirubin oxidative metabolites in septic patients: a new marker for oxidative stress"Journal of Surgical Research. 96. 44-49 (2001)
Kazuhiro Otani、Shuji Shimizu、Kazuo Chijiiwa 等人:“脓毒症患者胆红素氧化代谢物尿排泄增加:氧化应激的新标志物”《外科研究杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuhiro Otani, Shuji Shimizu, Kazuo Chijiiwa, et al.: "Increased urinary excretion of bilirubin oxidative metabolites in septic patients : a new marker for oxidative stress"Journal of Surgical Research. 96. 44-49 (2001)
Kazuhiro Otani、Shuji Shimizu、Kazuo Chijiiwa 等人:“脓毒症患者胆红素氧化代谢物尿排泄增加:氧化应激的新标志物”《外科研究杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuhiro Otani,Shuji Shimizu,Kazuo Chijiiwa,Koji Yamaguchi,Masao Tanaka: "Increased urinary excretion of bilirubin oxidative metabolites in septic patients : a new marker for oxidative stress"Journal of Surgical Research. (印刷中). (2001)
Kazuhiro Otani、Shuji Shimizu、Kazuo Chijiiwa、Koji Yamaguchi、Masao Tanaka:“脓毒症患者胆红素氧化代谢物尿排泄增加:氧化应激的新标志”《外科研究杂志》(2001 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Development of a new pharmacotherapy for heart failure using alpha-2 adrenergic agonists
Development of simulator for training of thoracic endovascular aneurysm repair
Establishment of new telemedicine system in Asia using academic high-speed Internet
  • 批准号:
    20406027
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.9万
  • 财政年份:
    2008
  • 负责人:
    SHIMIZU Shuji
  • 依托单位:
Effect of hyperbaric oxygen on hyperbiliri.ibinemia from the viewpoint of antioxidant activity of bilirubin
  • 批准号:
    14571209
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2002
  • 负责人:
    SHIMIZU Shuji
  • 依托单位:
国内基金
海外基金
脓毒症血浆胞外囊泡(Sepsis-EVs)通过S100A8/A9-RAGE-EEA1通路诱导急性肺损伤的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    夏杰
  • 依托单位:
miR-802靶向SDC4炎症反应信号通路调控sepsis相关性ALI的作用和机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    朱志鹏
  • 依托单位:
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
  • 批准号:
    82371770
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    宁铂涛
  • 依托单位:
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
  • 批准号:
    82372167
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    江继宏
  • 依托单位: